Synthgene Medical| Home self-test OTC hot hits are coming!
On April 1, 2022, SARS-CoV-2 (2019-nCoV) antigen detection kit (colloidal gold) developed by Nanjing Synthgene Technology Co., Ltd. (“ Synthgene”), a wholly-owned subsidiary of Jiangsu Synthgene Biotechnology Co., Ltd. Law) obtained the "Medical Device Registration Certificate" issued by the National Medical Products Administration (NMPA).
On April 1, 2022, Nanjing Synthgene Medical Technology Co., Ltd. (hereinafter referred to as "Synthgene"), a wholly-owned subsidiary of Jiangsu Synthgene Biotechnology Co., Ltd., developed the SARS-CoV-2 (2019-nCoV) antigen detection kit (colloidal gold method) and obtained the Medical Device Registration Certificate (registration number: National Machinery Specification 20223400427) issued by the State Drug Administration (NMPA).
The kit adopts the dual antibody sandwich method to qualitatively detect the SARS-CoV-2 (2019-nCoV) N antigen in human nasal swab samples in the form of solid phase immunochromatography, which is fast diagnosis, convenient to operate, and relatively low requirements for equipment and personnel for nucleic acid detection. It is mainly suitable for non-professionals outside medical institutions to use (that is, self-testing), and can achieve good detection effect on various VOCs such as the original strain, Alpha strain, Beta strain, Delta strain, Omicron strain, etc.
SARS-CoV-2 (2019-nCoV) antigen detection kit (colloidal gold method) multi-specification display
The SARS-CoV-2 antigen test kit approved by Synthgene is used to determine whether the subject has a SARS-CoV-2 infection by testing the subject's nasal swab. Whether it is from the simplicity of operation and the accuracy of the results, it is more in line with the current needs of SARS-CoV-2 testing. In the global epidemic prevention and control, Synthgene SARS-CoV-2 antigen rapid detection reagent has become a powerful detection tool!
Synthgene OTC home self-test product line
At present, the Synthgene OTC home self-inspection product line has covered infectious disease testing, drug testing, women's health and other fields.